Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2014
11/27/2014US20140349974 Zoledronic acid dosage forms for the treatment of pain
11/27/2014US20140349971 Combinations of A Pyrimidine Containing NNRTI with RT Inhibitors
11/27/2014US20140349969 Compounds and methods for treating pain
11/27/2014US20140349968 Compositions and Methods for Treating Cancer
11/27/2014US20140349967 Novel crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt
11/27/2014US20140349966 Boronate ester compounds and pharmaceutical compositions thereof
11/27/2014US20140349965 Compositions and methods for treating neoplastic diseases
11/27/2014US20140349964 Methods for inducing orexin neurons and agent for treating narcolepsy or eating disorder
11/27/2014US20140349963 Aqueous solution comprising a macromolecular conjugate of heparin for the treatment of blood vessels
11/27/2014US20140349962 Rapid two-step synthesis of anti-coagulants
11/27/2014US20140349961 Composition for enhancing intestine metabolism
11/27/2014US20140349960 Composition for body fat consumption
11/27/2014US20140349958 Novel indication and technique for the use of cross-linked hyaluronic acid in the management of pain
11/27/2014US20140349955 Use of fluorine-containing water soluble platinum complex in preparing drugs for prevention and treatment of cancers
11/27/2014US20140349953 Maillard reaction inhibitor
11/27/2014US20140349951 Compositions and Methods Related To Calcitriol
11/27/2014US20140349950 Sweetener composition for preventing and improving obesity, containing glycolysis inhibitor ingredient
11/27/2014US20140349945 Peg-amino acid-oligopeptide-irinotecan drug conjugates and the pharmaceutical compositions
11/27/2014US20140349937 Methods for treating benign prostatic hypertrophy (bph)
11/27/2014US20140349934 Method for inducing twin calving
11/27/2014US20140349933 Self-assembled composite ultrasmall peptide-polymer hydrogels
11/27/2014US20140349927 Ladostigil Therapy For Immunomodulation
11/27/2014US20140349923 Compositions And Methods For Treating Diabetes And/Or Obesity
11/27/2014US20140349918 Derivatives of xanthone compounds
11/27/2014US20140349292 Oligonucleotide n3'-->p5' thiophosphoramidates: their synthesis and use
11/27/2014US20140348966 Garcinia buchananii baker compounds, compositions and related methods
11/27/2014US20140348965 Use of a flavanol glycoside for suppressing activation of stellate cells
11/27/2014US20140348962 Method for Providing an Ingestible Nutritional Supplement to a Woman
11/27/2014US20140348960 Herbal ointment for musculoskeletal and joint-related conditions
11/27/2014US20140348959 Formulations and Methods for Treating Ear Conditions
11/27/2014US20140348958 Anticancer Active Ingredient From Guiera Senegalensis
11/27/2014US20140348957 Therapeutic and Method of Use
11/27/2014US20140348954 Product comprising glucomannan and chitosan for the treatment of gastroesophageal reflux disease
11/27/2014US20140348953 Morphine and morphine precursors
11/27/2014US20140348952 Magnesium-containing products and uses thereof
11/27/2014US20140348951 Dialysis precursor composition
11/27/2014US20140348950 Pyrrolidine- substituted flavone derivatives for prevention or treatment of oral mucositis
11/27/2014US20140348949 Om vitamin formula
11/27/2014US20140348939 Wound care product with egg shell membrane
11/27/2014US20140348938 Process for preparing solid lipid sustained release nanoparticles for delivery of vitamins
11/27/2014US20140348932 Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
11/27/2014US20140348931 Sustained-release topiramate formulations
11/27/2014US20140348930 Omega-3 Fatty Acid Ester Compositions
11/27/2014US20140348929 Omega-3 Fatty Acid Ester Compositions
11/27/2014US20140348926 Formulation and method for increasing oral bioavailability of drugs
11/27/2014US20140348923 Polymeric Drug-Delivery Material, Method For Manufacturing Thereof And Method For Delivery Of A Drug-Delivery Composition
11/27/2014US20140348922 Process for producing a particulate composition comprising an hydrous crystalline 2-o-alpha-d-glucosyl-l-ascorbic acid
11/27/2014US20140348921 Novel hemostatic composition
11/27/2014US20140348920 Method of Treating Multiple Sclerosis
11/27/2014US20140348918 Delayed-release glucocorticoid treatment of asthma
11/27/2014US20140348917 Immediate release formulations and dosage forms of gamma-hydroxybutyrate
11/27/2014US20140348916 Treatment of Pain with Oral Dosage Forms Comprising Zoledronic Acid and An Enhancer
11/27/2014US20140348915 Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
11/27/2014US20140348914 Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
11/27/2014US20140348910 Topical Formulations Including Lipid Microcapsule Delivery Vehicles and Their Uses
11/27/2014US20140348909 Pharmaceutical compositions of lurasidone
11/27/2014US20140348906 Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes
11/27/2014US20140348905 Gel compositions
11/27/2014US20140348903 Robust controlled-release formulations
11/27/2014US20140348901 Combinatorial methods and compositions for treatment of melanoma
11/27/2014US20140348900 Methods and devices for preparation of lipid nanoparticles
11/27/2014US20140348898 Local administration of gallium compositions to treat pain
11/27/2014US20140348889 Compositions and Methods for Treating and Preventing Neointimal Stenosis
11/27/2014US20140348883 Compositions and methods for enhancing brain function
11/27/2014US20140348879 Enteric soft capsules
11/27/2014US20140348878 Strain of exopolysaccharide-secreting lactobacillus brevis and application thereof
11/27/2014US20140348854 HE4 Based Therapy For Malignant Disease
11/27/2014US20140348853 Methods of treating rickettsia using exchange proteins directly activated by camp (epacs) inhibitors
11/27/2014US20140348850 Method for reducing blood pressure using inhibitors of plasma kallikrein
11/27/2014US20140348835 Anti-dll4/vegf dual variable domain immunoglobulin and uses thereof
11/27/2014US20140348827 Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof
11/27/2014US20140348824 Predictive biomarker of survival in the treatment of renal cell carcinoma
11/27/2014US20140348823 Histone Deacetylase (HDAC) Inhibitors for the Treatment of Cancer
11/27/2014US20140348819 Methods of Treating Cancer
11/27/2014US20140348818 Biomarkers of kawasaki disease
11/27/2014US20140348811 Compositions comprising sugar-cysteine products
11/27/2014US20140348810 Absorbable in situ gel-forming system, method of making and use thereof
11/27/2014US20140348796 Bifidobacteria for treating diabetes and related conditions
11/27/2014US20140348795 Nutritional beverage powder and method of making same
11/27/2014US20140348787 Methods and Compositions for Treating Ear Infections
11/27/2014US20140348784 Compositions and methods for treatment of angiogenesis in pathological lesions
11/27/2014US20140348783 Vaccine immunotherapy for immune suppressed patients
11/27/2014US20140348782 Vaccine immunotherapy for immune suppressed patients
11/27/2014US20140348780 Method of Enhanced Antibiotic Activity Via Chemotaxis
11/27/2014US20140348779 Ophthalmic composition
11/27/2014US20140348775 Wound treatment drug for external use
11/27/2014US20140348774 Method for treating wounds and tissue repair
11/27/2014US20140348772 Production of hydrogels by means of diels-alder reaction
11/27/2014US20140348764 Methods of Blocking Ultraviolet Radiation and Promoting Skin Growth Using Terpenes and Terpenoids
11/27/2014US20140348763 Compositions containing isosorbide monoester and alcohols that contain at least one aromatic group
11/27/2014US20140348758 Inhalable medicament comprising tiotropium
11/27/2014US20140348754 Method of Delivering Therapeutics and Imaging Agents to the Brain by Nanoparticles that Cross the Blood Brain Barrier
11/27/2014US20140348752 Methods for treating lysosomal acid lipase deficiency in patients
11/27/2014US20140345648 Oral Healthcare, Products and Methods Therefor
11/27/2014US20140345631 Nicotine salt formulations for aerosol devices and methods thereof
11/27/2014US20140345234 Method for Preparing a Nutritional Supplement for a Woman
11/25/2014USRE45261 Fatty acid niacin conjugates and their uses
11/25/2014US8895777 Compounds and compositions for delivering active agents
11/25/2014US8895756 Bendamustine pharmaceutical compositions
11/25/2014US8895755 Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity
1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 7860